astra construction inc.

90-04 sutphin blvd.
jamaica, new york 11435

NYS Entity Status
INACTIVE - Dissolution by Proclamation / Annulment of Authority (Sep 26, 1990)

NYS Filing Date
OCTOBER 04, 1983

NYS DOS ID#
871944

County
QUEENS

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
1983 - ASTRA CONSTRUCTION INC.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • 360 View: The Headache of Living Next to Endless Construction
    By RONDA KAYSEN - Friday Sep 15, 2017

    Construction scaffolding is a part of New York City’s streetscape. When it happens next door, developers sometimes pay neighbors for their trouble.

    Source: NYT > Home Page
  • British Columbia Vows to Block Pipeline Expansion
    Thursday Aug 10, 2017

    The government of British Columbia, Canada’s westernmost province, vowed to use every legal option to stop construction of Kinder Morgan Inc.’s planned expansion of a pipeline connecting the Alberta oil sands with the Pacific Coast.

    Source: The Wall Street Journal: World News
  • New Development: Soft in the Middle, Splashy Up Top
    By STEFANOS CHEN - Friday Sep 15, 2017

    The luxury market in New York is pulling in two directions, with developers betting on big-ticket palatial aeries and million-dollar “starter” homes.

    Source: NYT > Home Page
  • AstraZeneca CEO's Future Remains Shrouded in Mystery
    Friday Jul 14, 2017

    The mystery surrounding the intentions of the chief executive of AstraZeneca PLC, one of the world’s largest pharmaceutical firms, remains…a mystery.

    Source: The Wall Street Journal: U.S. Business
  • AstraZeneca Shocker Reminds Investors Miracle Drugs Are No Remedy for Risk
    Thursday Jul 27, 2017

    Chasing exciting new developments in medicine can be a very expensive endeavor. Such is the takeaway from AstraZeneca’s announcement that a hotly anticipated clinical trial didn’t meet expectations.

    Source: The Wall Street Journal: Markets News
  • AstraZeneca Shares Dive After Major Setback Over Cancer Drugs
    Thursday Jul 27, 2017

    AstraZeneca said a combination of two of its new oncology drugs failed to shrink lung cancer tumors in a clinical trial, casting doubt on a central part of its ambitious growth plans. Shares fell 16%.

    Source: The Wall Street Journal: U.S. Business
astra construction inc jamaica ny